Literature DB >> 3379300

Blood pressure and endogenous testosterone in men: an inverse relationship.

K T Khaw1, E Barrett-Connor.   

Abstract

Exogenous sex hormone use, including oral contraceptives, post-menopausal hormonal therapy and anabolic steroids, has been associated with blood pressure changes in both sexes, but little is known about the relationship between blood pressure and endogenous sex hormones. We examined this relationship in men in the Rancho Bernardo population study. Out of 1132 men aged 30-79 years, those with hypertension, categorically defined as systolic blood pressure (SBP) greater than 160 mmHg and/or diastolic blood pressure (DBP) greater than 95 mmHg had significantly lower testosterone levels than non-hypertensives. Systolic and diastolic blood pressure inversely correlated with testosterone levels (r = 0.17, P less than 0.001 for systolic; r = -0.15, P less than 0.001 for diastolic) in the whole cohort. This association was present over the whole range of blood pressures and sex hormone levels with a stepwise decrease in mean SBP and DBP per increasing quartile of testosterone. Obesity accounted for some, but not all, of this relationship, which was reduced, but still apparent after adjusting for age and body mass index. No other hormone (androstenedione, estrone, estradiol) nor sex hormone-binding globulin showed a consistent relationship with blood pressure. The clinical and physiological significance of this relationship merits further investigation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379300

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  39 in total

1.  Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study.

Authors:  T Vikan; S H Johnsen; H Schirmer; I Njølstad; J Svartberg
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082

Review 2.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

Review 3.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

4.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 5.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

6.  Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.

Authors:  Stella Yi; Elizabeth Selvin; Sabine Rohrmann; Shehzad Basaria; Andy Menke; Nader Rifai; Eliseo Guallar; Elizabeth A Platz; Brad Astor
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

7.  Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study.

Authors:  D Simon; P Preziosi; E Barrett-Connor; M Roger; M Saint-Paul; K Nahoul; L Papoz
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

8.  Peroxynitrite mediates testosterone-induced vasodilation of microvascular resistance vessels.

Authors:  Yashoda Puttabyatappa; John N Stallone; Adviye Ergul; Azza B El-Remessy; Sanjiv Kumar; Stephen Black; Maribeth Johnson; Mary P Owen; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

9.  Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues.

Authors:  Aditya Bagrodia; Christopher J Diblasio; Robert W Wake; Ithaar H Derweesh
Journal:  Indian J Urol       Date:  2009-04

Review 10.  Welcoming low testosterone as a cardiovascular risk factor.

Authors:  M Maggio; S Basaria
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.